title: Aripiprazole and neuroleptic malignant syndrome.
authors.forename: Julie
authors.initials: J
authors.lastname: Brunelle
authors.forename: Sandra
authors.initials: S
authors.lastname: Guigueno
authors.forename: Philippe
authors.initials: P
authors.lastname: Gouin
authors.forename: Fabienne
authors.initials: F
authors.lastname: Tamion
authors.forename: Florence
authors.initials: F
authors.lastname: Thibaut
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole